LISATA THERAPEUTICS, INC.
LSTA · Pharmaceutical Preparations
Latest available SEC filing: 3 ·
Latest disclosures
-
Farrow Jeffrey S: Form 3
Insider disclosure · Filed · Report period 13 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- LSTA · 128058302 - Common Stock, par value $0.001 per share
Company details and SEC sources
CIK 0000320017 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LSTA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 110 Allen Road, Second Floor, Basking Ridge, NJ, 07920
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
-
Caladrius Biosciences Inc. (to 15 Sep 2022) CALADRIUS BIOSCIENCES INC. (to 15 Sep 2022) NeoStem Inc. (to 05 Jun 2015) PHASE III MEDICAL INC/DE (to 01 Sep 2006) CORNICHE GROUP INC /DE (to 14 Aug 2003)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields